Comparative analysis of the biological and physical properties of enterococcus faecalis bacteriophage vB_EfaS_GEC-EfS_3 and streptococcus mitis bacteriophage vB_SmM_GEC-SmitiSM_2

Canadian Journal of Microbiology

Volumn 59, Issue 1, 2013, Pages 18-21

  Rigvava, Sophio ^a,b   Tchgkonia, Irina ^b   Jgenti, Darejan ^b   Dvalidze, Teona ^b   Carpino, James ^c   Goderdzishvili, Marina ^b  

^a ILIA STATE UNIVERSITY   (Georgia)

^b George Eliava Institute of Bacteriophage Microbiology and Virology   (Georgia)

^c CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

Bacteriophage therapy; Enterococcus faecalis; Infectious disease; Nosocomial infection; Streptococcus mitis

Indexed keywords

ADSORPTION; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; BACTERIOPHAGE; BACTERIUM; BIOTECHNOLOGY; COMPARATIVE STUDY; DIGESTIVE SYSTEM DISORDER; DISEASE TREATMENT; INFECTIOUS DISEASE; PATHOGEN; PHYSICAL PROPERTY; PUBLIC HEALTH; TEMPERATURE EFFECT; ULTRAVIOLET RADIATION;

ADSORPTION; ARTICLE; BACTERIOPHAGE; BACTERIUM ISOLATION; COMPARATIVE STUDY; ELECTRON MICROSCOPY; ENTEROCOCCUS FAECALIS; HIGH TEMPERATURE; HOST RANGE; NONHUMAN; PRIORITY JOURNAL; SEROLOGY; STREPTOCOCCUS MITIS; STREPTOCOCCUS PHAGE; SYPHOVIRIDAE; TEMPERATURE SENSITIVITY; ULTRAVIOLET RADIATION;

BACTERIOPHAGES; ENTEROCOCCUS FAECALIS; FEMALE; HOST SPECIFICITY; HUMANS; MICROSCOPY, ELECTRON, TRANSMISSION; SEROTYPING; STREPTOCOCCUS MITIS; STREPTOCOCCUS PHAGES; TEMPERATURE; ULTRAVIOLET RAYS;

EID: 84873590217     PISSN: 00084166     EISSN: 14803275     Source Type: Journal    
DOI: 10.1139/cjm-2012-0385     Document Type: Article

References (22)

1. Arias, C.A. 2008. Emergence and management of drug-resistant enterococcal infections. Expert Rev. Anti-Infect. Ther. 6(6): 637-655. doi:10.1586/14787210.6.5.637.
2. Bench, S.R., Hanson, T.E., Williamson, K.E., Ghosh, D., Radosovich, M., Wang, K., and Wommack, K.E. 2007. Metagenomic characterization of Chesapeake Bay virioplankton. Appl. Environ. Microbiol. 73: 7629-7641.doi:10.1128/AEM.00938-07. PMID:17921274.
3. Biswas, B., Adhya, S., Washart, P., Paul, B., Trostel, A.N., Powell, B., et al. 2002. Bacteriophage therapy rescues mice bacteremic from a clinical isolate of vancomycin-resistant Enterococcus faecium. Infect. Immun. 70: 204-210. doi:10.1128/IAI.70.1.204-210.2002. PMID:11748184.
4. Carlson, K. 2004. Working with bacteriophages: common techniques and methodological approaches. In Bacteriophages: biology and applications. Edited by E. Kutter and A. Sulakvelidze. CRC Press, Boca Raton, Fla., USA. pp. 437-494.
5. De, P.M., and Taddei, F. 2006. Viruses' life history: towards a mechanistic basis of a trade-off between survival and reproduction among phages. PLoS. Biol. 4: e193. doi:10.1371/journal.pbio.0040193. PMID:16756387.
6. Dennehy, J.J., and Turner, P.E. 2004. Reduced fecundity is the cost of cheating in RNA virus ψ6. Proc. Biol. Sci. 271: 2275-2282. doi:10.1098/rspb.2004.2833. PMID:15539353.
7. Ellis, E.L., and Delbruck, M. 1939. The growth of bacteriophage. J. Gen. Physiol. 22: 365-384. doi:10.1085/jgp.22.3.365. PMID:19873108.
8. Fisher, K., and Phillips, C. 2009. The ecology, epidemiology and virulence of Enterococcus. Microbiology, 155: 1749-1757. doi:10.1099/mic.0.026385-0. PMID:19383684.
9. Hanlon, G.W. 2007. Bacteriophages: an appraisal of their role in the treatment of bacterial infections. Int. J. Antimicrob. Agents, 30: 118-128. doi:10.1016/j.ijantimicag.2007.04.006. PMID:17566713.
10. Hatfull, G.F., Jacobs-Sera, D., Lawrence, J.G., Pope, W.H., Russell, D.A., Ko, C.C., et al. 2010. Comparative genomic analysis of 60 mycobacteriophage genomes: genome clustering, gene acquisition, and gene size. J. Mol. Biol. 397: 119-143. doi:10.1016/j.jmb.2010.01.011. PMID:20064525.
11. Hegstad, K., Mikalsen, T., Coque, T.M., Werner, G., and Sundsfjord, A. 2010. Mobile genetic elements and their contribution to the emergence of antimicrobial resistant Enterococcus faecalis and Enterococcus faecium. Clin. Microbiol. Infect. 16: 541-554. doi:10.1111/j.1469-0691.2010.03226.x. PMID:20569265.
12. Lee, Y.D., and Park, J.H. 2012. Complete genome sequence of enterococcal bacteriophage SAP6. J. Virol. 86(9): 5402-5403. doi:10.1128/JVI.00321-12. PMID:22492926.
13. Lu, T.K., and Koeris, M.S. 2011. The next generation of bacteriophage therapy. Curr. Opin. Microbiol. 14: 524-531. doi:10.1016/j.mib.2011.07.028. PMID: 21868281.
14. Murray, B.E. 2000. Vancomycin-resistant enterococcal infections. N. Engl. J. Med. 342: 710-721. doi:10.1056/NEJM200003093421007. PMID:10706902.
15. Ofner-Agostini, M., Johnston, B.L., Simor, A.E., Embil, J., Matlow, A., Mulvey, M., et al. 2008. Vancomycin-resistant enterococci in Canada: results from the Canadian nosocomial infection surveillance program, 1999-2005. Infect. Control Hosp. Epidemiol. 29: 271-274. doi:10.1086/528812. PMID:18241031.
16. Pajunen, M., Kiljunen, S., and Skurnik, M. 2000. Bacteriophage phiYeO3-12, specific for Yersinia enterocolitica serotype O:3, is related to coliphages T3 and T7. J. Bacteriol. 182: 5114-5120. doi:10.1128/JB.182.18.5114-5120.2000. PMID: 10960095.
17. Sood, S., Malhotra, M., Das, B.K., and Kapil, A. 2008. Enterococcal infections & antimicrobial resistance. Indian J. Med. Res. 128: 111-121. PMID:19001673.
18. Stent, G. 1963. Molecular biology of bacterial viruses. WH Freeman and Co., San Francisco, Calif., USA.
19. Sulakvelidze, A., Alavidze, Z., and Morris, J.G., Jr. 2001. Bacteriophage therapy. Antimicrob. Agents Chemother. 45: 649-659. doi:10.1128/AAC.45.3.649-659. 2001. PMID:11181338.
20. Theuretzbacher, U. 2012. Accelerating resistance, inadequate antibacterial drug pipelines and international responses. Int. J. Antimicrob. Agents, 39: 295-299. doi:10.1016/j.ijantimicag.2011.12.006. PMID:22341298.
21. Thurber, R.V. 2009. Current insights into phage biodiversity and biogeography. Curr. Opin. Microbiol. 12: 582-587. doi:10.1016/j.mib.2009.08.008. PMID: 19811946.
22. Udwadia, Z.F., Amale, R.A., Ajbani, K.K., and Rodrigues, C. 2012. Totally rugresistant tuberculosis in India. Clin. Infect. Dis. 54: 579-581. doi:10.1093/cid/cir889. PMID:22190562.